Speciality healthcare solutions company.
Issues relating to incentives for life sciences research.
H.R. 160: Protect Medical Innovation Act of 2015. Oversight of implementation of the America Invents Act.
Issues relating to patent settlements.
H.R. 9: The Innovation Act.
S. 1137: Protecting American Talent and Entrepreneurship Act of 2015 (PATENT Act).
Issues relating to misuse of the inter pares review process. Issues relating to bioequivalence and related administrative procedures.
Issues relating to prescription drug abuse.
Issues relating to incentives for tamper-resistant formulations.
Issues relating to Medicare Part D rebates.
Compounding and drug supply chain legislation.
H.R.471/S. 483: Ensuring Patient Access and Effective Drug Enforcement Act of 2015.
Issues relating to the labeling of generic drugs.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
THE GIBSON GROUP, LLC
601 Thirteenth Street, N.W., Suite B2 North, Washington, DC, 20005, US
JOSEPH H GIBSON JOSEPH H GIBSON JOSEPH H GIBSON (Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997)
Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997